Solifenacin Succinate

Description du produit

Solifenacin is an active substance for the treatment of overactive bladder. It is administered in the form of film-coated tablets.

Comprehensive documentation for drug registration of Solifenacin can be provided by Biesterfeld as referred.

CAS-No. Regulatory Monograph
242478-38-2 ASMF EP, USP

Tradename(s)

Solifenacin Succinate (Antimuscarinic)

Disponibilité pays

Disponible dans le monde entier

Georges Bertagne

Interlocuteur

Georges Bertagne

General Manager


email   phone

Interlocuteur

Brigitte Favre Bonnefoy

Head of Sales


email   phone